J.P. Morgan analyst Richard Vosser maintained a Hold rating on Sanofi (SNYNF – Research Report) today and set a price target of €100.00.

head of the Sanofi Pasteur vaccines division at the French drugmaker. "Welcoming Origimm within Sanofi expands our area of expertise by bringing extensive know-how in the field of skin microbiome ...

The newly merged company also formed a subsidiary known as Sanofi Pasteur, which is today one ... there are 65 new molecular entity projects and vaccine candidates already in clinical development.

Another pandemic influenza vaccine, Humenza® (Sanofi Pasteur, Lyon, France) contains the adjuvant AF03. Two studies in rats and rabbits have been reported using the adjuvant alone. Two rabbit ...

Similar to Sanofi Pasteur, they also label pre-filled syringes and employ vial caps with a unique color to differentiate each of its vaccines and have a statement on the packaging for Boostrix ...

GSK , Sanofi and CSL Ltd have secured $72 million from the U.S. government to ramp up production of bird flu vaccines, a ...

Sanofi (SNY), and CSL (CSLLY) win $72M U.S. contract to expand bird flu vaccine production amid fears of human transmission.

GSK Plc, Sanofi, and CSL Ltd. secured $72 million from the US government to ramp up production of bird flu vaccines as a nationwide outbreak among livestock and poultry has led to several human ...

As part of the agreement, GSK, Sanofi, and CSL will produce extra bulk vaccine components tailored to the circulating strains of avian influenza. Also Read: Medicare Drug Price Negotiation Program ...